Company Filing History:
Years Active: 2017
Title: Joern Dietrich: Innovator in Cell Proliferative Disorder Analysis
Introduction
Joern Dietrich is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the analysis of cell proliferative disorders, including cancer. His innovative work has the potential to improve patient outcomes through enhanced diagnostic methods.
Latest Patents
Joern Dietrich holds 1 patent for his invention titled "Methods and nucleic acids for analyses of cell proliferative disorders." This invention provides methods, nucleic acids, and kits for determining the prognosis of subjects with cell proliferative disorders. The invention discloses genomic sequences whose methylation patterns are useful for the improved detection of such disorders, thereby enabling better diagnosis and treatment for patients.
Career Highlights
Joern Dietrich is associated with Epigenomics AG, a company focused on developing innovative diagnostic solutions. His work at the company has been instrumental in advancing the understanding and treatment of cancer through molecular diagnostics.
Collaborations
Some of Joern's notable coworkers include Dimo Dietrich and Ralf Lesche. Their collaborative efforts contribute to the ongoing research and development in the field of epigenetics and cancer diagnostics.
Conclusion
Joern Dietrich's contributions to the analysis of cell proliferative disorders highlight the importance of innovation in medical diagnostics. His work not only enhances our understanding of cancer but also paves the way for improved patient care through advanced diagnostic techniques.